Press release
Neuropathic Pain Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Neuropathic Pain Market
The expansion of the neuropathic pain market is expected to be propelled by the increasing occurrence of chronic pain. Chronic pain, which is ongoing and extends beyond the usual recovery period of an illness or injury, typically persists for at least three to six months. The surge in chronic pain, including neuropathic conditions, necessitates effective therapeutic approaches, which in turn stimulates research, innovation, and spending in the development of better treatment options for improving symptom management and the quality of life. For illustration, the Scottish Health Survey conducted in 2022 by the Scotland-based Scottish Government revealed that in 2022, over one-third (38%) of Scottish adults experienced pain or discomfort for three months or more. The prevalence of such conditions was higher among women (43%) than men (33%). So, the escalating prevalence of chronic pain is a factor generating the growth of the neuropathic pain market. The neuropathic pain market is likely to expand further due to the anticipated increase in diabetes cases. Diabetes, a chronic medical condition involving elevated blood glucose levels, often results in neuropathies, which are the most common long-term complications of diabetes, affecting over 50% of diabetics during their lifetime. Diabetic peripheral neuropathy (DPN) is the most common type of such neuropathies and has the best-established treatment methods. For example, data from the UK's National Health Service (NHS) in June 2024 indicated a significant increase in the number of individuals under 40 affected by diabetes, from 173,166 in 2022 to 216,440 in 2023. This sharp increase underlines a worrying trend among the younger population and a quick increase in diabetes prevalence. Therefore, the surge in diabetes cases is spurring the growth of the neuropathic pain market.
Get Your Neuropathic Pain Market Report Here:
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
What is the projected compound annual growth rate (CAGR) of the neuropathic pain market from 2025 to 2034, and what factors influence it?
The market for neuropathic pain has been experiencing substantial growth in the past few years. The market, from being $5.35 billion in 2024, is projected to increase to $5.79 billion in 2025, marking an 8.2% compound annual growth rate (CAGR). The growth noted in the historical period resulted from a rise in the demand for drugs specialized for neuropathic pain, an escalating chronic pain epidemic, heightened demand for prescription-based treatments, and government initiatives.
The market for neuropathic pain is anticipated to witness substantial expansion in the coming years. It is projected to escalate to a value of $7.76 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. The upswing throughout the forecast period is likely due to the increased understanding of neuropathic pain, an ever-growing elderly population, a robust healthcare landscape, and the ease of accessing treatments for neuropathic pain. Notable trends for the forecast period encompass superior diagnostic methods, advancements in pain control techniques, medical research improvements, approval of new medicines, and strategic approaches.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12922&type=smp
How are the latest trends influencing the growth of the neuropathic pain market?
Leading firms in the neuropathic pain industry are utilizing artificial intelligence (AI) to provide innovative diagnosis, personalized treatment strategies, real-time assessment, pharmaceutical research, and data-informed perspectives to augment patient outcomes and optimize pain management methods. For instance, Nevro Corp., an American medical device company, in March 2023, introduced the Senza HFX iQ spinal cord stimulation (SCS) system. This cutting-edge technology employs AI to tailor pain relief to individual patients' needs. The system, encompassing the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger, and HFX App, is constructed to address non-surgical back pain and painful diabetic neuropathy by adjusting to patients' feedback and responses. It utilizes a unique algorithm derived from comprehensive patient data and allows patients to alter their pain relief regimen using a smartphone app. The digital architecture of the system enables data gathering and possible updates. The technology aspires to improve pain relief through regularity and personalization, symbolizing a significant development in SCS therapy.
What are the major segments of the neuropathic pain market and their role in driving growth?
The neuropathic pain market covered in this report is segmented -
1) By Treatment: Medications, Multimodal Therapy
2) By Diagnosis: Imaging, Blood Tests And Physical Examination
3) By Indication: Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications
4) By End User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Medications: Anticonvulsants, Antidepressants, Opioids, Topical Treatments, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Multimodal Therapy: Combination Of Medications, Physical Therapy, Psychological Therapy, Lifestyle Modifications, Complementary Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12922
Which regions are key players in the growth of the neuropathic pain market?
North America was the largest region in the neuropathic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the key firms paving the way for growth in the neuropathic pain market?
Major companies operating in the neuropathic pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Medtronic Inc., Eli Lilly and Company, Stryker Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Biogen Inc., Zimmer Biomet Holdings Inc., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., NuVasive Inc., Integer Holdings Corporation, Avanos Medical Inc., Orthofix Medical Inc., Nevro Corp., InvaGen Pharmaceuticals Inc., B. Braun Melsungen AG, Cirtec Medical Corp., Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, DePuy Synthes.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=12922&type=smp
What Is Covered In The Neuropathic Pain Global Market Report?
•Market Size Forecast: Examine the neuropathic pain market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the neuropathic pain market for a structured understanding.
•Key Players Overview: Analyze major players in the neuropathic pain market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the neuropathic pain market.
•Segment Contributions: Evaluate how different segments drive overall growth in the neuropathic pain market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the neuropathic pain market.
•Industry Challenges: Identify potential risks and obstacles affecting the neuropathic pain market.
•Competitive Landscape: Review strategic developments in the neuropathic pain market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3914793 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Neuropathic
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;…
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
